These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 1546132)

  • 1. Mode of action and characteristics of monoamine oxidase-A inhibition by moclobemide.
    Cesura AM; Kettler R; Imhof R; Da Prada M
    Psychopharmacology (Berl); 1992; 106 Suppl():S15-6. PubMed ID: 1546132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine oxidase inhibition by moclobemide and 2-amino-ethyl carboxamide derivatives: mode of action and kinetic characteristics.
    Cesura AM; Muggli-Maniglio D; Lang G; Imhof R; Da Prada M
    J Neural Transm Suppl; 1990; 32():165-70. PubMed ID: 2089085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of moclobemide on rat brain monoamine oxidase A and B: comparison with harmaline and clorgyline.
    Gerardy J
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):793-802. PubMed ID: 7938567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
    Da Prada M; Kettler R; Keller HH; Burkard WP; Muggli-Maniglio D; Haefely WE
    J Pharmacol Exp Ther; 1989 Jan; 248(1):400-14. PubMed ID: 2783611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of monoamine oxidase-A inhibition by moclobemide in vitro and ex vivo in rats.
    Kettler R; Da Prada M; Burkard WP
    Acta Psychiatr Scand Suppl; 1990; 360():101-2. PubMed ID: 2248058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-lasting and reversible inhibition of monoamine oxidase-A by moclobemide.
    Da Prada M; Kettler R; Keller HH; Burkard WP
    Acta Psychiatr Scand Suppl; 1990; 360():103-5. PubMed ID: 2248059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro].
    Gol'dina OA; Zagorevskiĭ VA; Lopatina KI; Sokolova TV; Gankina EM
    Biull Eksp Biol Med; 1986 Aug; 102(8):170-2. PubMed ID: 3742029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-clinical pharmacology of moclobemide. A review of published studies.
    Burkard WP; Da Prada M; Keller HH; Kettler R; Haefely W
    Br J Psychiatry Suppl; 1989 Oct; (6):84-8. PubMed ID: 2695131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemistry and pharmacology of moclobemide, a prototype RIMA.
    Haefely W; Burkard WP; Cesura AM; Kettler R; Lorez HP; Martin JR; Richards JG; Scherschlicht R; Da Prada M
    Psychopharmacology (Berl); 1992; 106 Suppl():S6-14. PubMed ID: 1546143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of moclobemide and selegiline on tyramine-evoked mydriasis in man.
    Bitsios P; Langley RW; Tavernor S; Pyykkö K; Scheinin M; Szabadi E; Bradshaw CM
    Br J Clin Pharmacol; 1998 Jun; 45(6):551-8. PubMed ID: 9663810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The action of befol and its derivatives on monoamine oxidase of different origins].
    Gol'dina OA; Moskvitina TA; Gankina EM; Kirkel' AZ; Kamyshanskaia NS; Lopatina KI; Sokolova TV; Zagorevskiĭ VA; Val'dman AV; Gorkin VZ
    Biull Eksp Biol Med; 1991 Mar; 111(3):279-80. PubMed ID: 2054504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical aspects of the pharmacology of moclobemide. The implications of animal studies.
    Callingham BA
    Br J Psychiatry Suppl; 1989 Oct; (6):53-60. PubMed ID: 2619973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. II. Biochemical characterization of monoamine oxidase inhibition.
    Kan JP; Steinberg R; Mouget-Goniot C; Worms P; Bizière K
    J Pharmacol Exp Ther; 1987 Jan; 240(1):251-8. PubMed ID: 3100771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some basic aspects of reversible inhibitors of monoamine oxidase-A.
    Da Prada M; Kettler R; Burkard WP; Lorez HP; Haefely W
    Acta Psychiatr Scand Suppl; 1990; 360():7-12. PubMed ID: 2248079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of moclobemide.
    Haefely W; Burkard WP; Cesura A; Colzi A; Kettler R; Lorez HP; Martin JR; Moreau JL; Richards JG; Schaffner R
    Clin Neuropharmacol; 1993; 16 Suppl 2():S8-18. PubMed ID: 8313402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between tyramine potentiation and monoamine oxidase (MAO) inhibition: comparison between moclobemide and other MAO inhibitors.
    Zimmer R
    Acta Psychiatr Scand Suppl; 1990; 360():81-3. PubMed ID: 2248084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAO-A inhibition in brain after dosing with esuprone, moclobemide and placebo in healthy volunteers: in vivo studies with positron emission tomography.
    Bergström M; Westerberg G; Németh G; Traut M; Gross G; Greger G; Müller-Peltzer H; Safer A; Eckernäs SA; Grahnér A; Långström B
    Eur J Clin Pharmacol; 1997; 52(2):121-8. PubMed ID: 9174681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical profiles of the novel reversible MAO-A inhibitors, moclobemide and brofaromine, in comparison with irreversible MAO inhibitors.
    Da Prada M; Kettler R; Keller HH; Burkard WP; Haefely WE
    J Neural Transm Suppl; 1989; 28():5-20. PubMed ID: 2677242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of reversible and selective inhibitors of monoamine oxidase type A.
    Finberg JP
    Acta Psychiatr Scand Suppl; 1995; 386():8-13. PubMed ID: 7717096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of neurochemical effects of the monoamine oxidase inhibitors phenelzine, moclobemide and brofaromine in the rat after short- and long-term administration.
    Urichuk LJ; Allison K; Holt A; Greenshaw AJ; Baker GB
    J Affect Disord; 2000 May; 58(2):135-44. PubMed ID: 10781703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.